Sector Perspective Therapeutics, Inc.

Aandelen

CATX

US46489V3024

Biotechnologie & Medisch Onderzoek

Beurs gesloten - NYSE 22:00:00 08-07-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
3,390 USD -0,88% Intraday-grafiek van Perspective Therapeutics, Inc. -2,02% +23,27%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-0,88%-2,02%+15,70%-22,43%+23,27%-3,97%-48,01%-55,34%-60,13% 390 mln.
-0,24%+1,85%+17,11%+12,66%+6,55%+3,13%+9,14%-14,40%+254,58% 49,74 mld.
-0,36%+1,21%+27,80%+96,14%+138,25%+420,77%+619,10%+497,89% - 40,49 mld.
-2,13%+0,29%+10,94%+18,11%-9,59%+23,91%-6,01%-18,09%+185,38% 34,75 mld.
-2,29%+3,83%+11,48%-3,30%-0,64%+23,48%+59,26%-5,69%+934,54% 34,35 mld.
-0,79%+1,32%+10,92%-8,10%+2,56%+5,78%+36,42%-19,16%+151,85% 26,98 mld.
+3,82%+3,51%+34,68% - - - - - - 16,58 mld.
-2,62%-2,13%+16,18%+2,18%-5,28%+64,96%+125,87%+195,25% - 15,6 mld.
-2,17%+6,65%+14,85%+12,64%+6,76%+104,31%+102,15%+117,74%+233,04% 14,27 mld.
-2,70%-2,04%+3,36%+2,70%+7,47%+12,37%+18,19%-33,60%+100,96% 13,76 mld.
-1,93%-5,47%+8,69%+55,31%-9,19%+9,16%-30,02%-20,96%+127,45% 12,92 mld.
-3,71%+3,91%+36,96%+20,89%+1,41%+1.682,48%+667,92%+318,87%+2.835,10% 12,49 mld.
-2,06%-2,24%+20,12%+27,93%+12,27%+41,40%+8,25%-40,94%+161,88% 11,01 mld.
+0,50%-0,06%+34,78%+28,53%+20,66%+34,70%-12,18%-38,41%+146,45% 11 mld.
-4,69%-7,03%+17,86%+20,57%-3,01%-2,12% - - - 10,79 mld.
-0,22%+0,36%+60,52%+60,31%+76,54%+265,97% - - - 10,01 mld.
-4,26%-0,04%+54,37%+31,02%+46,72%+162,86%+407,83%+129,88% - 9,81 mld.
-1,68%+4,97%+27,89%+56,14%+94,03%+84,79%+81,69%+113,40%+10,91% 9,2 mld.
-0,55%+11,90%+42,88%+37,20%+60,37%+181,83%+504,79%+208,39% - 9,06 mld.
+2,79%+4,19%+31,49%+3,99%+12,98%+612,13%+1.749,94%+12,12% - 9,03 mld.
Gemiddelde -1,31%+1,86%+24,93%+23,82%+25,38%+196,21%+252,61%+79,23%+423,50% 17,61 mld.
Gewogen gemiddelde per kap. -1,21%+2,36%+21,51%+25,86%+26,06%+166,29%+206,51%+93,68%+435,49%
Biotechnologie & Medisch Onderzoek - Andere
  1. Beurs
  2. Aandelen
  3. Koers CATX
  4. Sector Perspective Therapeutics, Inc.